Patents by Inventor Christopher J. Damien

Christopher J. Damien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8497236
    Abstract: The present invention provides compositions for an implantable putty material for delivery of active compounds to a patient. More specifically, the present invention provides a material having a pH of between about 3 and 6 and possessing putty-like physical properties, wherein the composition of the material includes collagen and water. The present invention also provides a method for using the implantable putty material.
    Type: Grant
    Filed: July 25, 2008
    Date of Patent: July 30, 2013
    Assignee: Zimmer Orthobiologics, Inc.
    Inventors: James J. Benedict, Christopher J. Damien
  • Patent number: 7709631
    Abstract: This application describes a bioresorbable biocellulose suitable for medical and surgical applications. In particular, the invention describes periodate oxidized microbial cellulose that can be produced to have any mechanical and degradation profile, depending on the desired application of the oxidized cellulose.
    Type: Grant
    Filed: January 31, 2007
    Date of Patent: May 4, 2010
    Assignee: Xylos Corporation
    Inventors: Jeremy J. Harris, Gonzalo Serafica, Christopher J. Damien, Heather R. Nonnenmann
  • Publication number: 20080293617
    Abstract: The present invention provides compositions for an implantable putty material for delivery of active compounds to a patient. More specifically, the present invention provides a material having a pH of between about 3 and 6 and possessing putty-like physical properties, wherein the composition of the material includes collagen and water. The present invention also provides a method for using the implantable putty material.
    Type: Application
    Filed: July 25, 2008
    Publication date: November 27, 2008
    Inventors: James J. Benedict, Christopher J. Damien
  • Publication number: 20070213522
    Abstract: This application describes a bioresorbable biocellulose suitable for medical and surgical applications. In particular, the invention describes periodate oxidized microbial cellulose that can be produced to have any mechanical and degradation profile, depending on the desired application of the oxidized cellulose.
    Type: Application
    Filed: January 31, 2007
    Publication date: September 13, 2007
    Inventors: Jeremy J. Harris, Gonzalo Serafica, Christopher J. Damien, Heather R. Nonnenmann
  • Publication number: 20040081704
    Abstract: The present invention provides compositions for an implantable putty material for delivery of active compounds to a patient. More specifically, the present invention provides a material having a pH of between about 3 and 6 and possessing putty-like physical properties, wherein the composition of the material includes collagen and water. The present invention also provides a method for using the implantable putty material.
    Type: Application
    Filed: December 17, 2003
    Publication date: April 29, 2004
    Applicant: Centerpulse Biologics Inc.
    Inventors: James J. Benedict, Christopher J. Damien
  • Patent number: 6679918
    Abstract: The present invention provides compositions for an implantable putty material for delivery of active compounds to a patient. More specifically, the present invention provides a material having a pH of between about 3 and 6 and possessing putty-like physical properties, wherein the composition of the material includes collagen and water. The present invention also provides a method for using the implantable putty material.
    Type: Grant
    Filed: February 13, 1998
    Date of Patent: January 20, 2004
    Assignee: Centerpulse Biologics Inc.
    Inventors: James J. Benedict, Christopher J. Damien
  • Publication number: 20020082697
    Abstract: Improved collagen-based osteogenic materials are disclosed that have improved shaping and handling properties and which are easier for the health care practitioner to use than conventional implantable osteogenic materials. The new shaped implantable compositions or devices also provide a good matrix for the release of osteogenic substances and other desirable biologically active agents at the site of implantation to promote bone growth.
    Type: Application
    Filed: December 22, 2000
    Publication date: June 27, 2002
    Inventor: Christopher J. Damien
  • Patent number: 5563124
    Abstract: Disclosed is a product which includes calcium carbonate and bone growth factor useful for the promotion of bone formation when implanted in the body. The calcium carbonate is preferably in the form of aragonite which can be recovered from naturally occurring coral. A preferred bone growth factor of the present invention is a protein mixture purified from bone. Also disclosed is a process for the induction of bone formation which includes implanting the product in a body. The product and process of the present invention are particularly useful in hip replacement operations, knee replacement operations, spinal fusion operations, repair of periodontal defects, treatment of osteoporosis, repair of bone tumor defects and repair of bone fractures.
    Type: Grant
    Filed: November 16, 1993
    Date of Patent: October 8, 1996
    Assignee: Intermedics Orthopedics/ Denver, Inc.
    Inventors: Christopher J. Damien, James J. Benedict, James W. Poser